Recently, it has been demonstrated that the acetylcholinesterase blocker galantamine improves cognitive deficit in schizophrenia, suggesting that a reduction in acetylcholine signaling may play a role in cognitive deficit [67]. Here, ACHE is linked to Cognitive impairment.